kaal:position:2026-07-31-5689

Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. should be assessed against Kaal's source-bound claim that The IEO reinserts an intermediary into token offerings: the exchange screens the offering and the issuer no longer interacts with investors directly, reversing the direct issuer to investor structure of the ICO. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

initial exchange offerings
token offerings listed on a cryptocurrency exchange
External evidence level: abstract indexed.
Mapping review tier: ambiguity triage before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity.

Scholarly basis

kaal:claim:3606663-010
Kaal, Digital Asset Market Evolution (2020). SSRN: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3606663
Source PDF sha256: d1d4a15a293b715bb6a5a32e689f59c3a1587915039ba9a1cf4eeb8ee2a1e57c

Evidence and mapping

Evidence: abstract indexed
Review tier: ambiguity triage before claim review
Mapping confidence: 0.1946
Mapping ambiguous: true

Topics

defisecurities-lawtokenomics

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0023 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: 5001e926c84b0814037fe7131778bcdc5365643c50236ad98fdd2fc1d5ce05a8
curl -s https://wulfkaal.github.io/positions/2026-07-31-5689.md | sha256sum